Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients

Minka J. A. Vries*, Heleen J. Bouman, Renske H. Olie, Leo F. Veenstra, Suzanne Zwaveling, Paul W. M. Verhezen, Arina J. ten Cate-Hoek, Hugo ten Cate, Yvonne M. C. Henskens, Paola E. J. van der Meijden

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)11-17
Number of pages7
JournalEuropean Heart Journal-Cardiovascular Pharmacotherapy
Volume3
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • Coronary artery disease
  • P2Y12 inhibitors
  • Platelet reactivity test
  • Concordance
  • Influencing factors
  • PERCUTANEOUS CORONARY INTERVENTION
  • LIGHT TRANSMISSION AGGREGOMETRY
  • ANTIPLATELET THERAPY
  • VERIFYNOW P2Y12
  • ADENOSINE-DIPHOSPHATE
  • MYOCARDIAL-INFARCTION
  • CLOPIDOGREL
  • REACTIVITY
  • ASSAYS
  • INHIBITION

Cite this